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Abstract 
BACKGROUND: Helminthiasis in school-aged children potentially causing physical growth and intellectual 
development retardation. Trichuriasis was the most common type of helminthiasis in children. 
AIM: To investigated the efficacy and side effects of albendazole, albendazole combined with levamisole and 
mebendazole combined with levamisole for trichuriasis and ascariasis. 
METHODS: This study was conducted as a double-blind, randomised clinical trial by comparing the efficacy and 
side effects of albendazole, albendazole combined with levamisole and mebendazole combined with levamisole 
for trichuriasis. The sample of this study were 180 elementary school students at Deli Serdang Regency State 
Elementary School, Medan, Indonesia. The study was conducted from April to June 2015. 
RESULT: The cure rate of helminthiasis on the 7th day was 81.7% after albendazole therapy, 88.3% after 
albendazole levamisole therapy, and 83.3% after mebendazole combined with levamisole therapy (p = 0.577). 
Cure rate on the 14th day was 88.3%, 95%, and 91.7% for albendazole, albendazole combined with levamisole, 
and mebendazole combined with levamisole therapy, respectively (p = 0.418). On the 21th day, the cure rate was 
88.3%, 96.7%, and 91.7% (p = 0.230). Combination of albendazole and levamisole showed the highest cure rate, 
despite the statistically insignificant difference for all groups (p > 0.05). Combination of albendazole combined 
with levamisole showed better cure rate for mild trichuriasis (95.8%) than albendazole therapy (46.2%) and 
mebendazole combined with levamisole (83.3%), (p < 0.05). 
CONCLUSION: Single-dose albendazole, a combination of albendazole and levamisole, and a combination of 
mebendazole and levamisole had similar efficacy in reducing egg count in helminthiasis. Combination of 
albendazole and levamisole showed better cure rate for mild trichuriasis and mixed infections. Side effects were 
similar in all treatment groups. 
 
 
 
 
 
 
Introduction 
 
Intestinal worm infection is still a major public 
health problem in Indonesia, especially in rural areas. 
In Indonesia and other developing countries, Ascaris 
lumbricoides, Trichuris trichiura, and hookworm are 
the most common intestinal parasites [1], [2]. World 
Health Organization (WHO) estimated that at least 
two billion people or nearly one-third of the world's 
population had been infected with soil-transmitted 
helminths (STH) or helminthiasis [3]. About 300 million 
infected people suffered from severe illness, and 
about 400 million school-aged children worldwide had 
been infected [4], [5]. 
Many species of worms had been reported to 
cause infection in Indonesia. Trichuris trichiura, was 
resided in the human caecum, was the most common 
cause of helminthiasis and one of the most important 
intestinal nematodes in human [6], [7].
 
School-age 
children were frequently infected with helminthiasis, 
which potentially causing diarrhoea, nutritional 
deficiency, anaemia, growth disorders, and intellectual 
disturbance [8], [9].
 
Public health program to control helminthiasis 
was largely dependent on the administration of anti-
helminthic drugs for elementary-school children [10]. 
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Theoretically, there were several broad-spectrum anti-
helminthic drugs such as albendazole, levamisole, 
mebendazole, and pyrantel pamoate with variable 
advantages and disadvantages [11], [12], [13], [14]. 
Benzimidazole group was the most common anti-
helminthic used in a public health setting [15], [16], 
[17].
 
We conducted a clinical trial to compare the 
efficacy and side effects of albendazole, albendazole 
with levamisole and mebendazole with levamisole 
therapy against trichuriasis and ascariasis in 
elementary-school children to determine the most 
effective regimen. 
 
 
Material and Methods 
 
This study was a double-blind, randomised 
clinical trial comparing the efficacy and side effects of 
albendazole, albendazole combined with levamisole 
and mebendazole combined with levamisole for 
trichuriasis. The sample of this study were 180 
elementary-school students at Deli Serdang Regency 
State Elementary School, Medan, Indonesia. The 
study was conducted from April to June 2015. Study 
steps consisted of preparation, data collection, 
processing, data analysis, and data improvement. 
 
Written informed consent was conducted by 
all subjects' parents or guardian two weeks before the 
scheduled intervention date. A container was given to 
each subject to keep their stool sample at home. The 
collected stool samples were qualitatively and 
quantitatively examined by the Kato-Katz method at 
Parasitology Laboratory of Medical Faculty, University 
of Sumatera Utara, Medan. Stool sample with a 
positive finding of trichuriasis was randomised as the 
study subjects into the three treatment groups. Stool 
sample examination for evaluation was done on day 
7, day 14 and 21 after treatment. 
Each subject in the first group was given one 
tablet of 400 mg albendazole. Second group was 
given one tablet of 400 mg albendazole and 2 tablets 
of 25 mg levamisole (for children weighed 10 – 20 kg), 
or one tablet of 400 mg albendazole and 4 tablets of 
25 mg levamisole (for children weighed 21 – 40 kg), or 
one tablet of 400 mg albendazole and 6 tablets of 25 
mg levamisole (for children weighed > 40 kg). The 
third group was given one tablet of 500 mg 
mebendazole and levamisole dose is the same as the 
second group. For the following 14 days, parents were 
instructed to record any side effect after treatment. 
Comparison of recovery rate between the intervention 
groups was analysed using Chi-square test or 
Wilcoxon test as suitable. The p-value of less than 
0.05 was considered significant. 
 
Results 
 
There were 807 Deli Serdang elementary 
students; after the exclusion, we found 185 students 
with helminthiasis based on stool examination. Five of 
them had started therapy before the study. Therefore, 
they were excluded. The remaining 180 students were 
study subjects who undergone randomisation into 
three intervention groups (60 students in each group). 
The characteristics of the subjects can be seen in 
Table 1.  
Table 1: Characteristics of Subjects 
Characteristics First Group 
Albendazole 
Second Group 
Albendazole + 
Levamisole 
Third Group 
Mebendazole + 
Levamisole 
(N = 60) (N = 60) (N = 60) 
  
Age, years (mean ± SD) 
 
9.2 ± 1.734 
 
8.9 ± 1.540 
 
9.1 ± 1.567 
Sex, n (%)     
Male, n (%) 35 (58.3) 28 (46.7) 31 (51.7) 
Female, n (%) 25 (41.7) 32 (53.3) 29 (48.3) 
Weight, kg  27.2 ± 7.957 27.1 ± 6.374 27.9 ± 7.363 
Height, cm (mean ± SD)  
Wight/height (mean ± SD) 
129.5 ± 13.944 
97.1 ± 6.574 
132.0 ± 18.516 
95.7 ± 13.014 
128.4 ± 12.785 
94.1 ± 17.757 
Parental occupation 
Entrepreneur 
Farmer 
Civil servant 
Others 
 
38 (16.7) 
11 (18.3) 
1 (1.6) 
10 (16.6) 
 
14 (23.3) 
45 (75) 
- 
1 (1.6) 
 
16 (26.6) 
38 (63.3) 
1 (1.6) 
5 (8.3) 
Parental education, n (%) 
Uneducated 
Elementary school 
Junior high school 
Senior high school 
University 
Helminthiasis (%) 
A. lumbricoides 
T. Trichur 
A. lumbricoides + T. trichura 
A. lumbricoides + T. trichura 
+ Enterobiuss 
 
1 (0.83) 
22 (18.33) 
46 (38.33) 
3 (35.83) 
8 (6.67) 
 
47 (78.3) 
6 (10) 
7 (11.7) 
- 
 
7 (5.83) 
36 (30) 
38 (31.67) 
39 (32.5) 
- 
 
34 (56.7) 
19 (31.0) 
7 (11.7) 
- 
 
13 (10.83) 
25 (20.83) 
42 (35) 
38 (31.67) 
2 (1.67) 
 
11 (18.3) 
12 (20) 
36 (60) 
1 (1.7) 
 
The most common helminthiasis was infection 
by Ascaris lumbricoides, followed by mixed infection 
by Ascaris lumbricoides with Trichuris trichuria, 
Trichuris trichuria only, and mixed infection by Ascaris 
lumbricoides with Trichuris trichuria and Enterobius 
vermicularis as seen in Table 2.  
Table 2: Prevalence of helminthiasis 
Helminthiasis Etiology Numbers (%) 
Ascaris lumbricoides  92 (51.11) 
Trichuris trichiura  37 (20.55) 
A. lumbricoides + T. trichiura  50 (27.78) 
A. lumbricoides + T. trichiura + E. vermicularis 1 (0.56) 
 
Subjects with mild A. lumbricoides infection 
were 50 children (83.3%) in the first group, 39 
students (65%) in the second group, and 46 students 
(76.7%) in the third group. Subjects with mild T. 
trichuria infection were 13 children (21.7%) in the first 
group, 24 children (40%) in the second group, and 24 
children (40%) in the third group.  
Table 3: Basic Characteristics of Research Based on Intensity 
of Infection 
Characteristics First Group 
Albendazole 
(N = 60) 
Second Group 
Albendazole + 
Levamisole 
(N = 60) 
Third Group 
Mebendazole + 
Levamisole 
(N = 60) 
The intensity of infection, n (%) 
Ascaris lumbricoides 
Mild  50 (83.3) 39 (65) 46 (76.7) 
Moderate 4 (6.7) 2 (65) 1 (1.7) 
Trichuris trichiura 
Mild 
Moderate 
 
13 (21.7) 
- 
 
24 (40) 
2 (3.3) 
 
24 (40) 
1 (1.7) 
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The Statistical analysis did not show a 
significant reduction in egg count on the 7
th
 day after 
therapy in all groups, whereas there was a significant 
reduction in the 14
th
 and 21st day in all groups. 
Determination of egg reduction rate can be seen in 
Table 4. 
Table 4: Egg Reduction Rate on Day 7
th
, 14
th
, 21
th
 
 
Parasites 
 
Antihelmintics 
regiment 
Total eggs per gram 
Mean (SD) 
7
th
 day 
Mean (SD) 
14
th
 day 
Mean (SD) 
21
st
 day 
P value 
A. lumbricoides Albendazole 34.00 ± 165.64 - - 0.651 
Albendazole 
+ Levamisole 
14.40 ± 111.54 - -  
Mebendazole 
+ Levamisole 
34.80 ± 126.25 - -  
T. trichiura Albendazole 33.60 ± 95.91 24.80 ± 81.23 20.40 ± 74.96 0.247 
Albendazole 
+ Levamisole 
20.00 ± 89.38 12.40 ± 73.47 7.60 ± 47.89  
Mebendazole 
+ Levamisole 
40.00 ± 122.66 18.80 ± 68.03 8.80 ± 29.63  
 
The cure rate of helminthiasis on the 7
th
 day 
was 81.7% after albendazole therapy, 88.3% after 
albendazole + levamisole therapy, and 83.3% after 
mebendazole + levamisole therapy (p = 0.577). Cure 
rate on the 14
th
 day was 88.3%, 95%, and 91.7% for 
albendazole, albendazole + levamisole, and 
mebendazole + levamisole therapy, respectively (p = 
0.418). On the 21th day, the cure rate was 88.3%, 
96.7%, and 91.7% (p = 0.230). Combination of 
albendazole and levamisole showed the highest cure 
rate, despite the statistically insignificant difference for 
all groups (p > 0.05). Determination of cure rates 
analysis can be seen in Table 5. 
Table 5: The Cure Rates Analysis On Day 7
th
, 14
th
, 21
th 
 
Recovery 
Therapy Recovered Not Recovered P 
n % n % 
Albendazole (Day-7) 49 81.7 11 18.3 0.577 
Albendazol + Levamisole (Day-7) 53 88.3 7 11.7  
Mebendazol + Levamisole (Day-7) 50 83.3 10 16.7  
Albendazole (Day-14) 53 88.3 7 11.7 0.418 
Albendazole + Levamisole (Day-14) 57 95.0 3 5.0  
Mebendazole + Levamisole (Day-14) 55 91.7 5 8.3  
Albendazole (Day-21) 53 88.3 7 11.7 0.230 
Albendazol + Levamisole (Day-21) 58 96.7 2 3.3  
Mebendazol + Levamisole (Day-21) 55 91.7 5 8.3  
 
Combination of albendazole combined with 
levamisole showed better cure rate for mild 
trichuriasis (95.8%) than albendazole therapy (46.2%) 
and mebendazole + levamisole (83.3%), p = 0.00. 
Determination of cure rate mild helminthiasis analysis 
can be seen in Table 6 and Table 7. 
Table 6: The Cure Rate of Mild Helminthiasis 
 Recovery 
Parasite(s) Treatment Cured Not Cured P 
n % n % 
A. lumbricoides Albendazole 46 92 4 8 0.176 
Albendazole + Levamisole 39 100 - -  
Mebendazole + Levamisole 42 91.3 4 8.7  
T. trichiura Albendazole 6 46.2 7 53.8 0.01 
Albendazole + Levamisole 23 95.8 1 4.2  
Mebendazole + Levamisole 20 83.3 4 16.7  
 
The side effects during the treatment process 
in each group had been observed. Side effect 
observed in the albendazole group were 13.3%, 
Albendazole combined with Levamisole was 26.7%, 
and Mebendazole combined with Levamisole were 20 
%. 
Table 7: Cure Rate of Each Intervention Group 
Parasite(s) Intervention Cure Rate (%) P Value 
A. lumbricoides Albendazole 100 - 
Albendazole + Levamisole 100  
Mebendazole + Levamisole 100  
T. trichiura Albendazole 66.7 0.136 
Albendazole + Levamisole 94.7  
Mebendazole + Levamisole 92.3  
A. lumbricoides +  
T. trichiura 
Albendazole 28.6 0.079 
Albendazole + Levamisole 85.7  
Mebendazole-Levamisole 66.7  
 
Observation data of side effect can be seen in 
Table 8 
Table 8: Side Effects analysis  
Side Effect Albendazole 
n (%) 
Albendazole + Levamisole 
n (%) 
Mebendazole + Levamisole 
n (%) 
None 52 (86.7) 44 (73.3) 48 (80.0) 
Yes 8 (13.3) 16 (26.7) 12 (20.0) 
 
 
 
Discussion 
 
Helminthiasis has still been a major health 
problem in Indonesia. A. lumbricoides, T. trichiura and 
hookworm (N. americanus and A. duodenale) were 
the most common aetiology. WHO data on 2012 
reported a high prevalence of helminthiasis in North 
Sumatera, i.e. 80% of school-aged children [18], [19]. 
Statistical analysis did not show a significant 
reduction in egg count on the 7
th
 day after therapy in 
all groups, whereas there was a significant reduction 
in the 14
th
 and 21st day in all groups. Even after the 
reduction in egg number at 14
th
 and 21st day, we still 
found several T. trichuria eggs in subjects’ stool, 
indicating the difficulty in eradicating trichuriasis as 
mentioned in the literature [20]. A study by Saputri in 
2010 found significant egg reduction rate in single-
dose mebendazole and mebendazole with levamisole 
therapy for A. lumbricoides and T. trichuria infections 
[21]. The contradictive result was found by Sihite et 
al., (2014) and Knopp et al., (2010) study, which found 
no significant difference in the treatment with 
mebendazole, albendazole, and mebendazole with 
levamisole [22], [23].
 
Based on Table 5, the combination of 
albendazole and levamisole showed the highest cure 
rate, despite the statistically insignificant difference for 
all groups (p > 0.05). Therefore, this finding indicated 
the similar efficacy of albendazole, albendazole + 
levamisole, and mebendazole + levamisole therapy. 
Based on Table 6, the combination of 
albendazole with levamisole showed better cure rate 
for mild trichuriasis (95.8%) than albendazole therapy 
(46.2%) and mebendazole combined with levamisole 
(83.3%), p = 0.01. We hypothesised that levamisole 
had enhanced efficacy than albendazole and 
mebendazole for mild trichuriasis. Previous studies 
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showed that a single dose of albendazole or 
mebendazole had 28% and 36% recovery rate, 
respectively [16], [23].
 
For mixed infection, 
albendazole combined with levamisole was more 
effective (cure rate 85.7%) than single albendazole 
(28.65%) or mebendazole combined with levamisole 
(66.7%), p = 0.079 that showed on Table 7. A study 
by Sihite et al., (2014) found no significant difference 
in the recovery of helminthiasis with mebendazole + 
levamisole or single mebendazole therapy [22]. 
Another study found no significant differences in the 
recovery rate of helminthiasis between mebendazole 
with or without levamisole therapy [21].
 
The most 
common side effects in all groups were nausea and 
diarrhoea. No serious side effects were observed in 
this study, and mild side effects had recovered by 
their own. Table 8 shows that there was no difference 
in side effects between intervention groups. 
 
 It can be concluded that single-dose 
albendazole, a combination of albendazole and 
levamisole, and the combination of mebendazole and 
levamisole had similar efficacy in reducing egg count 
in helminthiasis. Combination of albendazole and 
levamisole showed better cure rate for mild 
trichuriasis and mixed infections. Side effects were 
similar in all treatment groups.  
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